A collaborative research group has developed a novel therapeutic candidate that may improve the prognosis of severe cutaneous ...

Leishmaniasis belongs to the class of neglected tropical diseases (NTDs) that particularly affect people in the poorest ...

A new preliminary study published in Nature suggests that COVID-19 vaccines might actually boost the immune system to make ...

Preclinical study showed PDIA1 and PDIA5 protect cells from oxidative stress, maintain mitochondrial function, and are ...

Syndax received expanded FDA approval for Revuforj, tripling its addressable AML patient population despite a boxed safety ...

King’s College London researchers discovered that parts of our DNA once thought to be “junk” can actually help destroy cancer ...

Combining proteasome inhibitors with autophagy inhibitors disrupts acute myeloid leukemia (AML) cells' proteostasis, ...

The study was a randomized, double-blind, placebo-controlled, proof-of-concept trial designed to inform the design of a Phase ...

The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.

The drug, which is an NLRP3 inhibitor, also reduced other key cardiovascular risk biomarkers. Ventyx Biosciences plans to ...